Effect of placenta previa on umbilical cord hematocrit value

Basit Öğe Kaydı
dc.authoridHalici-Ozturk, Filiz/0000-0002-4494-5167
dc.authoridcaglar, ali turhan/0000-0002-7022-3029
dc.contributor.authorHalici-Ozturk, Filiz
dc.contributor.authorBeyazit, Fatma
dc.contributor.authorYakut, Kadriye
dc.contributor.authorYucel Yetiskin, Fatma Didem
dc.contributor.authorOzturk, Merve
dc.contributor.authorSinaci, Selcan
dc.contributor.authorCaglar, A. Turhan
dc.date.accessioned2025-01-27T20:55:54Z
dc.date.available2025-01-27T20:55:54Z
dc.date.issued2022
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractObjective Placenta previa is one of the causes of neonatal anemia. This condition is mainly explained by antenatal hemorrhage and incision of the anteriorly located placenta during cesarean section. However, the mechanism of neonatal anemia in placenta previa has not been extensively studied or well elucidated. This study investigates whether placenta previa is associated with lower hematocrit levels in newborns with no antenatal hemorrhage and placental incision. Key findings This prospective study investigated 47 patients with previa and 43 control patients who gave birth with a cesarean section at 34-38 weeks of gestation. Blood samples were obtained from the fetal end of the umbilical vein. The mean umbilical cord hematocrit value was 49.3% in the control patients and 46.7% in the patients with previa, and the difference was statistically significant (p = .029). No significant association was observed between hematocrit value and birth weight, gestational age, newborn gender, placenta position, or preoperative maternal hemoglobin level. Conclusion The study findings reveal that even if not complicated by antepartum or intrapartum hemorrhage, placenta previa may be associated with lower hematocrit values in newborns. Although in none of the cases, the umbilical cord hematocrit value was not as low as to be defined as anemia, this effect of previa on newborns should be considered because of the importance of iron status.
dc.identifier.doi10.1080/14767058.2022.2128651
dc.identifier.endpage10367
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.issue26
dc.identifier.pmid36176062
dc.identifier.scopus2-s2.0-85141089478
dc.identifier.scopusqualityQ1
dc.identifier.startpage10362
dc.identifier.urihttps://doi.org/10.1080/14767058.2022.2128651
dc.identifier.urihttps://hdl.handle.net/20.500.12428/26231
dc.identifier.volume35
dc.identifier.wosWOS:000862603800001
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.ispartofJournal of Maternal-Fetal & Neonatal Medicine
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectPlacenta previa
dc.subjectumbilical cord blood
dc.subjectneonatal anemia
dc.subjectantepartum hemorrhage
dc.subjectplacental incision
dc.titleEffect of placenta previa on umbilical cord hematocrit value
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu